Literature DB >> 18540826

Pathogen-associated molecular pattern in cancer immunotherapy.

Uwe Hobohm1, John L Stanford, John M Grange.   

Abstract

Observations from different research frontiers--epidemiological data, case studies on spontaneous regressions from cancer, clinical studies, tumor immunology--indicate that exposure by vaccination or infection to pathogen-associated molecular patterns (PAMP) can have beneficial effects on neoplastic diseases, both prophylactically and therapeutically. These effects have not yet been harnessed to their full extent for the prophylaxis and therapy of cancer. Here, we summarize clinical, epidemiological, and experimental data and discuss the role of PAMP in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540826     DOI: 10.1615/critrevimmunol.v28.i2.10

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  13 in total

Review 1.  Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy.

Authors:  Gang Xin; David M Schauder; Ryan Zander; Weiguo Cui
Journal:  Immunotherapy       Date:  2017-09       Impact factor: 4.196

2.  Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III study.

Authors:  Jianhua Chang; Yunpeng Liu; Baohui Han; Caicun Zhou; Chunxue Bai; Jin Li
Journal:  Med Oncol       Date:  2015-03-24       Impact factor: 3.064

3.  A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity.

Authors:  Rebekah Watkins-Schulz; Pamela Tiet; Matthew D Gallovic; Robert D Junkins; Cole Batty; Eric M Bachelder; Kristy M Ainslie; Jenny P Y Ting
Journal:  Biomaterials       Date:  2019-03-14       Impact factor: 12.479

Review 4.  Chronic inflammation as a manifestation of defects in immunoregulatory networks: implications for novel therapies based on microbial products.

Authors:  O Bottasso; G Docena; J L Stanford; J M Grange
Journal:  Inflammopharmacology       Date:  2009-07-14       Impact factor: 4.473

Review 5.  Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.

Authors:  Eileena F Giurini; Mary Beth Madonna; Andrew Zloza; Kajal H Gupta
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

6.  Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy.

Authors:  Che-Wei Hu; You-Chiun Chang; Cheng-Hao Liu; Yao-An Yu; Kurt Yun Mou
Journal:  Mol Ther       Date:  2022-04-18       Impact factor: 12.910

7.  Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin.

Authors:  C Maletzki; U Klier; W Obst; B Kreikemeyer; M Linnebacher
Journal:  Clin Dev Immunol       Date:  2012-11-11

8.  In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth.

Authors:  Michael Bordonaro; Senji Shirasawa; Darina L Lazarova
Journal:  Cancers (Basel)       Date:  2016-05-14       Impact factor: 6.639

Review 9.  Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.

Authors:  Ivan Y C Lin; Thi Thu Hao Van; Peter M Smooker
Journal:  Vaccines (Basel)       Date:  2015-11-10

Review 10.  Coley's Lessons Remembered: Augmenting Mistletoe Therapy.

Authors:  Maurice Orange; Uwe Reuter; Uwe Hobohm
Journal:  Integr Cancer Ther       Date:  2016-05-20       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.